Investment analysts at HC Wainwright raised their Q1 2025 EPS estimates for ArriVent BioPharma in a report issued on Wednesday, January 22nd. HC Wainwright analyst R. Burns now anticipates that the ...
GLJ Research lowered its price target on JinkoSolar Holding Co., Ltd. (NYSE:JKS) to $10.95 from $13.08, while maintaining a Sell rating. The firm cited concerns over potential tariffs from the Trump ...
Keros Therapeutics (KROS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price ...
In this article, we will take a look into The Goldman Sachs Group Inc's (NYSE:GS) DCF analysis, a reliable and data-driven approach to estimating its intrinsic value. Instead of using future free cash ...